Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy

Overview

Journal Breast Care (Basel)

Publisher Karger

Date 2018 Oct 16

PMID 30319325

Citations 6

Authors

Octavi Cordoba

Lourdes Carrillo-Guivernau

Carmen Reyero-Fernandez

Affiliations

Soon will be listed here.

Abstract

Neoadjuvant therapy (NAT) allows downstaging in some cases of breast cancer. By consequence, it may enable a more conservative surgical approach or make surgery possible in cases ineligible for surgery before NAT. In this article, we review the evidence and management recommendations for optimal surgical treatment in this setting.

Citing Articles

How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?.

Ali O, Elhaj A Breast Care (Basel). 2023; 18(5):336-343.

PMID: 37901048 PMC: 10601675. DOI: 10.1159/000531151.

Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Torrent A, Amengual J, Sampol C, Ruiz M, Rioja J, Matheu G Cancers (Basel). 2022; 14(4).

PMID: 35205676 PMC: 8870578. DOI: 10.3390/cancers14040929.

Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments.

Reis J, Lindstrom J, Boavida J, Gjesdal K, Park D, Bahrami N Breast Cancer Res Treat. 2020; 184(2):407-420.

PMID: 32789592 PMC: 7599143. DOI: 10.1007/s10549-020-05852-7.

Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field.

Escriva-de-Romani S, Arumi M, Zamora E, Bellet M Breast Care (Basel). 2018; 13(4):251-262.

PMID: 30319327 PMC: 6170905. DOI: 10.1159/000492122.

Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer.

Pernaut C, Lopez F, Ciruelos E Breast Care (Basel). 2018; 13(4):244-249.

PMID: 30319326 PMC: 6170899. DOI: 10.1159/000491759.

References

Feliciano Y, Mamtani A, Morrow M, Stempel M, Patil S, Jochelson M . Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?. Ann Surg Oncol. 2017; 24(6):1492-1498. PMC: 5485840. DOI: 10.1245/s10434-016-5741-y. View

Sakamoto N, Fukuma E, Tsunoda Y, Teraoka K, Koshida Y . Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker. Breast Cancer. 2018; 25(5):575-582. DOI: 10.1007/s12282-018-0854-8. View

Wang K, Ren Y, He J . Cavity Shaving plus Lumpectomy versus Lumpectomy Alone for Patients with Breast Cancer Undergoing Breast-Conserving Surgery: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1):e0168705. PMC: 5207394. DOI: 10.1371/journal.pone.0168705. View

Kim J, Park H, Kim S, Ryu J, Park S, Kim S . Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer. Medicine (Baltimore). 2015; 94(43):e1720. PMC: 4985376. DOI: 10.1097/MD.0000000000001720. View

. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2017; 19(1):27-39. PMC: 5757427. DOI: 10.1016/S1470-2045(17)30777-5. View

Chagpar A, Killelea B, Tsangaris T, Butler M, Stavris K, Li F . A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer. N Engl J Med. 2015; 373(6):503-10. PMC: 5584380. DOI: 10.1056/NEJMoa1504473. View

Rubio I, Esgueva-Colmenarejo A, Espinosa-Bravo M, Salazar J, Miranda I, Peg V . Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment. Ann Surg Oncol. 2015; 23(1):38-43. DOI: 10.1245/s10434-015-4935-z. View

Fisher B, Saffer E, Rudock C, Coyle J, Gunduz N . Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res. 1989; 49(8):2002-4. View

Pernaut C, Lopez F, Ciruelos E . Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer. Breast Care (Basel). 2018; 13(4):244-249. PMC: 6170899. DOI: 10.1159/000491759. View

10.

Chan B, Wiseberg-Firtell J, Jois R, Jensen K, Audisio R . Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev. 2016; (12):CD009206. PMC: 8881987. DOI: 10.1002/14651858.CD009206.pub2. View

11.

Scholl S, Asselain B, Palangie T, Dorval T, Jouve M, GARCIA GIRALT E . Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer. 1991; 27(12):1668-71. DOI: 10.1016/0277-5379(91)90442-g. View

12.

Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert F . Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010; 46(8):1296-316. DOI: 10.1016/j.ejca.2010.02.015. View

13.

Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E . Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989; 49(8):1996-2001. View

14.

Semiglazov V, Eiermann W, Zambetti M, Manikhas A, Bozhok A, Lluch A . Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study. Eur J Surg Oncol. 2011; 37(10):856-63. DOI: 10.1016/j.ejso.2011.07.003. View

15.

Caudle A, Yang W, Mittendorf E, Black D, Hwang R, Hobbs B . Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2014; 150(2):137-43. PMC: 4508192. DOI: 10.1001/jamasurg.2014.1086. View

16.

Hunt K, Yi M, Mittendorf E, Guerrero C, Babiera G, Bedrosian I . Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009; 250(4):558-66. DOI: 10.1097/SLA.0b013e3181b8fd5e. View

17.

Boughey J, McCall L, Ballman K, Mittendorf E, Ahrendt G, Wilke L . Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg. 2014; 260(4):608-14. PMC: 4159769. DOI: 10.1097/SLA.0000000000000924. View

18.

Tan V, Goh B, Fook-Chong S, Khin L, Wong W, Yong W . The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis. J Surg Oncol. 2011; 104(1):97-103. DOI: 10.1002/jso.21911. View

19.

Straver M, Loo C, Alderliesten T, Rutgers E, Vrancken Peeters M . Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010; 97(8):1226-31. DOI: 10.1002/bjs.7073. View

20.

Kim Y, Chang J, Moon H, Lee J, Shin S, Moon W . Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size. Ann Surg Oncol. 2015; 23(4):1135-42. DOI: 10.1245/s10434-015-4993-2. View